GoodRx Downgraded Amid Consumer Relevance Concerns

lunes, 9 de marzo de 2026, 11:14 am ET1 min de lectura
GDRX--

GoodRx's stock has been downgraded due to its losing relevance with consumers. The company's sales growth has slowed down, and it is struggling to compete with newer health and wellness apps. The stock market has been volatile, with negative catalysts such as AI "SaaSpocalypse" fears and rising geopolitical tensions in the Middle East.

GoodRx Downgraded Amid Consumer Relevance Concerns

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios